These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35718789)

  • 21. Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial).
    Kang MK; Park SY; Park JS; Kim HJ; Kim JG; Kang BW; Baek JH; Cho SH; Seo AN; Kim DW; Kim J; Baek SJ; Kim JH; Kim JY; Ha GW; Park EJ; Park IJ; Kim CH; Kang H; Choi GS
    BMC Cancer; 2023 Nov; 23(1):1059. PubMed ID: 37923987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
    Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y
    Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
    Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer.
    Wyrwicz L; Saunders M; Hall M; Ng J; Hong T; Xu S; Lucas J; Lu X; Lautermilch N; Formenti S; Glynne-Jones R
    Radiother Oncol; 2023 Aug; 185():109669. PubMed ID: 37054987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.
    Langheinrich M; Paasch C; Mantke R; Weber K; Benz S; Kersting S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12591-12596. PubMed ID: 37438538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized total neoadjuvant therapy versus chemotherapy during the 'wait period' versus standard chemoradiotherapy for locally advanced rectal cancer.
    Bedrikovetski S; Traeger L; Fitzsimmons T; Perry J; Vather R; Moore JW; Sammour T
    ANZ J Surg; 2023 May; 93(5):1267-1273. PubMed ID: 36573638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
    Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
    Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
    Kim MJ; Lee DW; Kang HC; Park JW; Ryoo SB; Han SW; Kim KS; Chie EK; Oh JH; Jeong WK; Kim BH; Nam EM; Jeong SY
    BMC Cancer; 2023 Aug; 23(1):734. PubMed ID: 37553666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy on organ preservation in locally advanced rectal cancer.
    Liao CK; Kuo YT; Hsu YJ; Chern YJ; Yu YL; Lin YC; Hsieh PS; Chiang JM; Yeh CY; You JF
    Int J Colorectal Dis; 2023 Apr; 38(1):92. PubMed ID: 37022513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer.
    Lin Z; Cai M; Zhang P; Li G; Liu T; Li X; Cai K; Nie X; Wang J; Liu J; Liu H; Zhang W; Gao J; Wu C; Wang L; Fan J; Zhang L; Wang Z; Hou Z; Ma C; Yang K; Wu G; Tao K; Zhang T
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34725214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).
    Zhang H; Li Y; Xia F; Sun Y; Shen L; Wan J; Chen Y; Wang Y; Zhou M; Wu R; Zhou S; Wang Y; Liu F; Cai S; Zhang Z
    BMJ Open; 2024 Feb; 14(2):e079442. PubMed ID: 38309748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial.
    Dijkstra EA; Hospers GAP; Kranenbarg EM; Fleer J; Roodvoets AGH; Bahadoer RR; Guren MG; Tjalma JJJ; Putter H; Crolla RMPH; Hendriks MP; Capdevila J; Radu C; van de Velde CJH; Nilsson PJ; Glimelius B; van Etten B; Marijnen CAM
    Radiother Oncol; 2022 Jun; 171():69-76. PubMed ID: 35447283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis.
    Liu SX; Zhou ZR; Chen LX; Yang YJ; Hu ZD; Zhang TS
    Asian Pac J Cancer Prev; 2015; 16(14):5755-62. PubMed ID: 26320447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial.
    Zheng R; Wang BS; Li Z; Chi P; Xu B
    BMJ Open; 2023 Mar; 13(3):e066976. PubMed ID: 36927585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review.
    Yang L; Cui X; Wu F; Chi Z; Xiao L; Wang X; Liang Z; Li X; Yu Q; Lin X; Gao C
    Front Immunol; 2024; 15():1392499. PubMed ID: 38846948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
    Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
    JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
    Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.
    Prajapati R; Ostwal V; Srinivas S; Engineer R; Bhargava P; Saklani A; D'Souza A; Kumar S; Peelay Z; Manali P; Ramaswamy A
    J Cancer Res Ther; 2024 Jan; 20(1):199-203. PubMed ID: 38554321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.